|
EnzySurge Ltd. is a developer and provider of innovative solutions for the treatment and management of chronic wounds.
EnzySurge's flagship DermaStream™ platform based on the proprietary Continuous Streaming Therapy (CST™) offers a new and unique wound treatment modality by continuously streaming a fresh supply of advanced bio-active therapeutic solutions to a controlled wound environment.
DermaStream™ is designed to deliver effective, affordable and easy-to-use wound treatment throughout all phases of chronic wound treatment cycle from debridement, through regeneration to wound closure. DermaStream™ was designed for use in hospitals, clinics and for home care.
EnzySurge is committed to the development and delivery of innovative solutions that improve the quality of life of chronic-wound patients by shortening healing time, preventing hospitalization and reducing treatment costs.
|
